Previous 10 | Next 10 |
With all the attention that COVID-19-related companies have gotten over the past couple of months, it's easy to forget that there are plenty of other promising stocks out there to invest in. Although it's true that this pandemic has changed the way many companies do business, there are still ton...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its 2020 Annual Meeting of Stockholders (“Annual Meeting”) will be held in a virtual-only format due to continued public health concerns relating to COVID-...
Diabetes is a severe chronic health condition that affects about 34.2 million people in the U.S. alone, which represents approximately 10% of the country's population. Many more people -- an estimated one in three Americans -- are at risk of developing diabetes. Fortunately, many companies deve...
Amended regulations issued by the Food & Drug Administration (FDA), including in response to the COVID-19 pandemic, are expected to turbocharge revenues for diabetes companies and leading to analyst upgrades. According to the latest 2020 statistics compiled by the Centers for Disease Cont...
Tandem Diabetes Care (NASDAQ: TNDM ) has priced its $250M aggregate principal amount of 1.50% Convertible Senior Notes due 2025 in a private placement, for estimated net proceeds of ~$242.5M. More news on: Tandem Diabetes Care, Inc., Healthcare stocks news, , Read more ...
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem” or, the “Company”) announced today the pricing of $250.0 million aggregate principal amount of 1.50 percent Convertible Senior Notes due 2025 (the “Notes”) in a private placement to persons rea...
Tandem Diabetes Care (NASDAQ: TNDM ) intends to offer $250M aggregate principal amount of Convertible Senior Notes due 2025 in a private placement. More news on: Tandem Diabetes Care, Inc., Healthcare stocks news, , Read more ...
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) (“Tandem” or, the “Company”) announced today that it intends to offer, subject to market conditions and other factors, $250.0 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes&...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present a company update at the following virtual investor conferences: BofA Securities 2020 Health Care...
Image source: The Motley Fool. Tandem Diabetes Care Inc (NASDAQ: TNDM) Q1 2020 Earnings Call Apr 30, 2020 , 4:30 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
Tandem Diabetes Care Inc. Company Name:
TNDM Stock Symbol:
NASDAQ Market:
Tandem Diabetes Care Inc. Website:
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Friday. The Dow traded up 1.27% to 38,712.21 whil...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 2% on Friday. The Dow traded up 1.16% to 38,670.87 while the NA...
2024-05-03 16:34:00 ET Tandem Diabetes Care (NASDAQ: TNDM) stock exploded higher after reporting a sales beat Thursday evening. Analysts forecast the maker of t:slim X2 insulin pumps would lose $0.76 per share on sales of $174 million in 2024's first quarter. Tandem did lose mon...